No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 Breastfeeding
Breast milk is superior in nutrition, It provides resistance against infections and allergies, It is naturally sterile. Despite all the advantages of breastfeeding some mothers choose to pause the breastfeeding in fear of harmful effects of medicines passing in breast milk. Are you wondering about breastfeeding and using No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 ? Know what is No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 and how it can affect your breast milk and whether No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 is safe for your kid or not.

What is No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 used for?


Directions Use as a normal foundation Apply evenly at least 15 minutes before sun exposure Reapply as needed Not intended for children under the age of 12 Not intended for protection while sunbathing

Purpose: Uses Provides moderate protection against adverse effects of the sun Higher SPF gives more protection

Can I continue breastfeeding if I am using No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10? How long does it stays in breast milk?

No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 high risk while breastfeeding
No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 consists two active ingredients Octinoxate and Titanium dioxide and as per our analysis of both we have determined the No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 in breastfeeding.

Octinoxate and Breastfeeding

Unsafe

Is No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 safe while breastfeeding

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.


What if I already have used No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 usage and time interval of breastfeeding.


My doctor has prescribed me No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 then there must be good reason for that as No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of No7 Lifting And Firming Foundation Sunscreen Spf 15 New Ivory 10 in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients